Contact Information: Contacts: The Global Consulting Group Rachel Levine T: (646) 284-9439 E: rlevine@hfgcg.com
Cleveland BioLabs Celebrates Opening of Corporate Headquarters Building
| Source: Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwire - October 25, 2007) - Cleveland BioLabs, Inc. (NASDAQ : CBLI ) (BOST : CBLI ) will celebrate the opening of its new corporate headquarters on the
Buffalo Niagara Medical campus in Buffalo, NY with an official
ribbon-cutting ceremony today.
Representatives of Roswell Park Cancer Institute and the Buffalo Niagara
Medical Campus, as well as several New York State legislators will join
Cleveland BioLabs management and staff for the festivities.
Dr. Michael Fonstein, Chief Executive Officer and President of Cleveland
BioLabs and the entire senior management team express their gratitude to
Roswell Park Cancer Institute, the Buffalo Niagara Medical Campus and
Buffalo Niagara Enterprise for welcoming the Company to Buffalo and
supporting its relocation efforts.
About Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. is a drug discovery and development company
leveraging its proprietary discoveries about programmed cell death to treat
cancer and protect normal tissues from exposure to radiation and other
stresses. The Company has strategic partnerships with the Cleveland Clinic
Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the
Armed Forces Research Radiobiology Institute. To learn more about
Cleveland BioLabs Inc., please visit the company's website at
http://www.cbiolabs.com.
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995. Forward-looking
statements reflect management's current expectations, as of the date of
this press release, and involve certain risks and uncertainties. Our actual
results could differ materially from those anticipated in these
forward-looking statements as a result of various factors. Some of the
factors that could cause future results to materially differ from the
recent results or those projected in forward-looking statements include the
"Risk Factors" described in our periodic filings with the Securities and
Exchange Commission.